Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.
about
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice.In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.Endocannabinoid system and pain: an introduction.Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling.Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.Endocannabinoids, related compounds and their metabolic routes.Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Inflammation of peripheral tissues and injury to peripheral nerves induce differing effects in the expression of the calcium-sensitive N-arachydonoylethanolamine-synthesizing enzyme and related molecules in rat primary sensory neurons.New perspectives for chronic pain treatment: a patent review (2010-2016).Endocannabinoids in nervous system health and disease: the big picture in a nutshell.Alterations in the anandamide metabolism in the development of neuropathic pain.Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.
P2860
Q35939665-84CAE59C-0909-441C-8A4C-946BE9FEBA98Q37637750-1A031D61-6A01-4B10-9B8F-00C2B1C6787DQ38154691-67B9D280-B73D-4347-A3EF-606BD3B0FA7FQ38185067-33018EE8-99EC-4D63-AF0F-FBEDBD002E70Q38212376-679791AB-DDBF-4E5B-9199-FFA116CD8184Q38262964-F05A651D-D2F4-4A29-BA96-4EE2A8862326Q38727831-A8652238-24AF-4C2E-9D54-67627852CE40Q39084202-134BDA6D-C96B-448A-B2E9-C62552F73CBDQ39361658-34E15827-7923-4FEA-9EE2-C4CE2663220AQ42112685-CF4258F3-B1AE-4707-89A4-B26A4BAAB003Q42211454-17A250F4-3194-44C4-A872-B81696CA449BQ42707296-9B50C803-3BEC-49AA-8079-AD737F21425DQ43075742-6C514A3F-C347-4529-9435-EF696A26EE9BQ47159533-6B90EB96-7023-47A9-B229-FC7E51D24468Q47591608-2786954D-BEF4-40B4-AEEA-081BC645FA72
P2860
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modulation of neuropathic-pain ...... nabinoid/endovanilloid system.
@en
type
label
Modulation of neuropathic-pain ...... nabinoid/endovanilloid system.
@en
prefLabel
Modulation of neuropathic-pain ...... nabinoid/endovanilloid system.
@en
P2860
P356
P1476
Modulation of neuropathic-pain ...... nabinoid/endovanilloid system.
@en
P2860
P304
P356
10.1098/RSTB.2011.0392
P407
P577
2012-12-01T00:00:00Z